MedTrace Logo

A Single Preoperative Dose of Gabapentin to Decreases Postoperative Pain in Ambulatory Anal Surgeries

NCT05533684 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-03-16

No results posted yet for this study

Summary

Single dose 600 mg gabapentin will be given preoperatively in anal surgeries

Conditions

  • Pain, Postoperative

Interventions

DRUG

Gabapentin

single preoperative dose of 600 mg gabapentin

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Sarah Omar, M.D. · Minia University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05533684 on ClinicalTrials.gov